Kimia Farma
Kimia Farma, officially known as PT Kimia Farma Tbk, is a prominent player in Indonesia's pharmaceutical industry, headquartered in Jakarta. Established in 1817, it stands as one of the oldest pharmaceutical companies in the country, with a rich history marked by significant milestones in healthcare innovation and accessibility. The company operates extensively across Indonesia, focusing on the production and distribution of a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and herbal remedies. Kimia Farma is renowned for its commitment to quality and affordability, making healthcare accessible to a broader population. With a strong market position, Kimia Farma has achieved notable recognition for its extensive network of pharmacies and healthcare services, contributing significantly to Indonesia's healthcare landscape. Its dedication to research and development further solidifies its reputation as a leader in the pharmaceutical sector.
DitchCarbon Score
How does Kimia Farma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kimia Farma's score of 17 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Kimia Farma's reported carbon emissions
In 2022, Kimia Farma reported total carbon emissions of approximately 509,246,840 kg CO2e, all of which were classified under Scope 1 emissions. There is no reported data for Scope 2 or Scope 3 emissions for that year. The company has not disclosed any specific reduction targets or initiatives, nor does it appear to have cascaded any Science-Based Targets Initiative (SBTi) commitments from its parent company, PT Kimia Farma Tbk. Looking at previous years, Kimia Farma's emissions were significantly higher in 2021, with about 1,085,841,150 kg CO2e, and approximately 193,144,650 kg CO2e in 2020. This indicates a notable reduction in emissions from 2021 to 2022. However, the absence of detailed climate commitments or reduction initiatives suggests that while there has been a decrease in emissions, a structured approach to long-term sustainability may be lacking. As a current subsidiary of PT Kimia Farma Tbk, Kimia Farma's emissions data and climate strategies are influenced by the broader corporate family context, but specific initiatives or targets have not been disclosed. The company operates within the pharmaceutical industry, which is increasingly focusing on sustainability and carbon reduction, yet Kimia Farma's current commitments remain unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 193,144,650 | 0,000,000,000 | 000,000,000 |
| Scope 2 | - | - | - |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kimia Farma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
